• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Duchenne Muscular Dystrophy Market

Global Duchenne Muscular Dystrophy Market Analysis 2012-2017 and Forecast 2018-2023


Summary
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Deflazacort
        Prednisone
        Others
        
        
        
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
        PTC Therapeutics
        Sarepta Therapeutics
        Bristol-Myers Squibb
        ITALFARMACO
        BioMarin
        Daiichi Sankyo
        Solid Biosciences
        Summit Therapeutics
        FibroGen
        NS Pharma
        Pfizer
        ReveraGen BioPharma
        Wave Life
        Genethon
        Santhera Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        Male
        Female
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
        North America
        Europe
        Asia-Pacific
        South America
        Middle East & Africa	
Table of Content
1 Industry Overview
    1.1 Duchenne Muscular Dystrophy Industry
        1.1.1 Overview
        1.1.2 Development of Duchenne Muscular Dystrophy
    1.2 Market Segment
        1.2.1 Upstream
        1.2.2 Downstream
    1.3 Cost Analysis
2 Industry Environment
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
3 Duchenne Muscular Dystrophy Market by Type
    3.1 By Type
       3.1.1 Deflazacort
       3.1.2 Prednisone
       3.1.3 Others
    3.2 Market Size
    3.3 Market Forecast
4 Major Companies List
    4.1 PTC Therapeutics (Company Profile, Sales Data etc.)
    4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
    4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
    4.4 ITALFARMACO (Company Profile, Sales Data etc.)
    4.5 BioMarin (Company Profile, Sales Data etc.)
    4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)
    4.7 Solid Biosciences (Company Profile, Sales Data etc.)
    4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
    4.9 FibroGen (Company Profile, Sales Data etc.)
    4.10 NS Pharma (Company Profile, Sales Data etc.)
    4.11 Pfizer (Company Profile, Sales Data etc.)
    4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
    4.13 Wave Life (Company Profile, Sales Data etc.)
    4.14 Genethon (Company Profile, Sales Data etc.)
    4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
5 Market Competition
    5.1 Company Competition
    5.2 Regional Market by Company
6 Market Demand
    6.1 Demand Situation
        6.1.1 Demand in Male
        6.1.2 Demand in Female
    6.2 Regional Demand Comparison
    6.3 Demand Forecast
7 Region Operation
    7.1 Regional Output
    7.2 Regional Market
    7.3 by Region
        7.3.1 North America
            7.3.1.1 Overview
            7.3.1.2 by Country (U.S., Canada, Mexico)
        7.3.2 Europe
            7.3.2.1 Overview
            7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
        7.3.3 Asia-Pacific
            7.3.3.1 Overview
            7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
        7.3.4 South America
            7.3.4.1 Overview
            7.3.4.2 by Country (Brazil, Argentina etc.)
        7.3.5 Middle East & Africa
            7.3.5.1 Overview
            7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
    7.4 Regional Forecast
8 Marketing & Price
    8.1 Price and Margin
        8.1.1 Price Trends
        8.1.2 Factors of Price Change
        8.1.3 Manufacturers Gross Margin Analysis
    8.2 Value Chain
    8.3 Marketing Channel
9 Research Conclusion

	Table Upstream Segment of Duchenne Muscular Dystrophy
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market 2012-2023, by Application, in USD Million
Table Major Company List of Deflazacort
Table Major Company List of Prednisone
Table Major Company List of Others
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Type, in Volume
Table Global Duchenne Muscular Dystrophy Market Forecast 2017-2023, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market Forecast 2017-2023, by Type, in Volume
Table PTC Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Duchenne Muscular Dystrophy Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ITALFARMACO Overview List
Table Duchenne Muscular Dystrophy Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Overview List
Table Duchenne Muscular Dystrophy Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Duchenne Muscular Dystrophy Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Solid Biosciences Overview List
Table Duchenne Muscular Dystrophy Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Summit Therapeutics Overview List
Table Duchenne Muscular Dystrophy Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FibroGen Overview List
Table Duchenne Muscular Dystrophy Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NS Pharma Overview List
Table Duchenne Muscular Dystrophy Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Duchenne Muscular Dystrophy Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ReveraGen BioPharma Overview List
Table Duchenne Muscular Dystrophy Business Operation of ReveraGen BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Wave Life Overview List
Table Duchenne Muscular Dystrophy Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genethon Overview List
Table Duchenne Muscular Dystrophy Business Operation of Genethon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Santhera Pharmaceuticals Overview List
Table Duchenne Muscular Dystrophy Business Operation of Santhera Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Duchenne Muscular Dystrophy Sales Revenue 2012-2017, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume 2012-2017, by Company, in Volume
Table Global Duchenne Muscular Dystrophy Sales Volume Share 2012-2017, by Company, in Volume
Table Duchenne Muscular Dystrophy Demand in Male, 2012-2017, in USD Million
Table Duchenne Muscular Dystrophy Demand in Male, 2012-2017, in Volume
Table Major Consumers in Male
Table Duchenne Muscular Dystrophy Demand in Female, 2012-2017, in USD Million
Table Duchenne Muscular Dystrophy Demand in Female, 2012-2017, in Volume
Table Major Consumers in Female
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Duchenne Muscular Dystrophy Demand Forecast 2017-2023, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand Forecast 2017-2023, by Application, in Volume
Table Duchenne Muscular Dystrophy Output 2012-2017, by Region, in USD Million
Table Duchenne Muscular Dystrophy Output 2012-2017, by Region, in Volume
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market Share 2012-2017, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2012-2017, by Region, in Volume
Table Global Duchenne Muscular Dystrophy Market Share 2012-2017, by Region, in Volume
Table North America Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in USD Million
Table North America Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in Volume
Table Europe Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in USD Million
Table Europe Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in Volume
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in USD Million
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in Volume
Table South America Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in USD Million
Table South America Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in Volume
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in USD Million
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2012-2017, by Country, in Volume
Table Duchenne Muscular Dystrophy Market Forecast 2017-2023, by Region, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast 2017-2023, by Region, in Volume
Table Price Factors List Figure Duchenne Muscular Dystrophy Industry Chain Structure
Figure Global Duchenne Muscular Dystrophy Market Growth 2012-2017, by Type, in USD Million
Figure Global Duchenne Muscular Dystrophy Market Growth 2012-2017, by Type, in Volume
Figure North America Duchenne Muscular Dystrophy Market, by Company, in 2017
Figure Europe Duchenne Muscular Dystrophy Market Market, by Company, in 2017
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Market, by Company, in 2017
Figure South America Duchenne Muscular Dystrophy Market Market, by Company, in 2017
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Market, by Company, in 2017
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in USD Million
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in Volume
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in USD Million
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in Volume
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in USD Million
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in Volume
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in USD Million
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in Volume
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in USD Million
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview

Related Reports

Global Glaucoma Treatment Drugs Market Grade and Outlook 2015-2025

Snapshot The global Glaucoma Treatment Drugs market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Produc ...read more

Global Glycoprotein 41 Market Grade and Outlook 2015-2025

Snapshot The global Glycoprotein 41 market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Product Type et ...read more

Global Glycosylated Biosimilars Market Grade and Outlook 2015-2025

Snapshot The global Glycosylated Biosimilars market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Produc ...read more

Global Green Coffee Extract Market Grade and Outlook 2015-2025

Snapshot The global Green Coffee Extract market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Product Ty ...read more

Global Gutta-percha Root Canal Obturator Market Grade and Outlook 2015-2025

Snapshot The global Gutta-percha Root Canal Obturator market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.